{
  "docId": "019de071-eb84-776b-8e7d-ce40a476afec",
  "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02",
  "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 105,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide uses a five-column layout to categorize the company's strategic approach.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/13",
  "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec",
  "deckJsonHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec.json",
  "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.61,
        "y": 0.46
      },
      "kind": "chart",
      "text": "Survival curve chart",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8351d3ec-8e24-4fab-ac7e-653655b08130",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.41,
        "y": 0.67
      },
      "kind": "chart",
      "text": "Absolute IRAK4 Levels chart",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b30b9bd5-a21a-4a66-bb34-30c9a4c287bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.02,
        "y": 0.65
      },
      "kind": "image",
      "text": "Molecular structure icons",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f2caba3-fdf1-4fb7-bb45-f52bf44f5d37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.41,
        "y": 0.18
      },
      "kind": "list",
      "text": "CLINICAL: Innovative clinical trial designs for degrader development",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06b3ded9-a83c-4cbb-bc96-36ea8f4b2749",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.18,
        "x": 0.21,
        "y": 0.18
      },
      "kind": "list",
      "text": "PLATFORM: Significantly differentiated investments; Tissue-selective E3 Ligases; New Molecular Glue Approach",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "18c6ed5b-4bd5-4e74-bb0e-aa2f04279de1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.18,
        "x": 0.61,
        "y": 0.18
      },
      "kind": "list",
      "text": "TPD \"FIRSTS\": Kymera has accomplished several \"firsts\" in TPD; KT-474/IRAK4; KT-333/STAT3",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1dc0a52a-55da-449d-b720-942168e7a2a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.18,
        "x": 0.02,
        "y": 0.18
      },
      "kind": "list",
      "text": "TARGET SELECTION: Unique approach focused on undrugged or not fully drugged targets with broad indication potentials",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "363146f1-ebcb-453f-ac1d-0a78a96c1142",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.81,
        "y": 0.18
      },
      "kind": "list",
      "text": "INNOVATION: Serious commitment to constant evolution of our science",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb8f928d-ff6a-4a37-be5a-b2cc6e35dfc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.58,
        "x": 0.21,
        "y": 0.04
      },
      "kind": "title",
      "text": "Kymera’s Differentiated Approach to TPD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d53b691-686d-498b-94e1-1acc7f92b765",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "360de855-1cbd-4b8f-b0c2-e6a6ca0baf41",
      "evidence": "The slide uses bullet points to list key aspects of Kymera's approach to TPD, similar to a list presentation.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 11,
      "beatId": "86cb8a6d-db8c-40e2-814e-5bc67b50c2e5",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "The deck showcases Kymera's pipeline, clinical trials, and potential for broad activity across diseases, creating a desire for the solution.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "7d2f21f7-c191-4e6f-8cc3-d5255feabd13",
      "evidence": "The deck presents a series of slides explaining the problem, complication, and solution, forming a logic chain.",
      "position": 0,
      "objective": "To demonstrate the logic behind Kymera's TPD approach and its potential to expand the druggable proteome.",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}